Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
454.86%
operating margin TTM
-637.92%
revenue TTM
7.81 Million
revenue per share TTM
0.14$
valuation ratios | |
|---|---|
| pe ratio | 5.41 |
| peg ratio | 0.02 |
| price to book ratio | 2.72 |
| price to sales ratio | 27.26 |
| enterprise value multiple | 5.92 |
| price fair value | 2.72 |
profitability ratios | |
|---|---|
| gross profit margin | 51.93% |
| operating profit margin | -637.92% |
| pretax profit margin | 455.56% |
| net profit margin | 454.86% |
| return on assets | 33.32% |
| return on equity | 41.4% |
| return on capital employed | -55.39% |
liquidity ratios | |
|---|---|
| current ratio | 5.89 |
| quick ratio | 5.70 |
| cash ratio | 1.98 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 316.12 |
| operating cycle | 484.54 |
| days of payables outstanding | 212.58 |
| cash conversion cycle | 271.96 |
| receivables turnover | 2.17 |
| payables turnover | 1.72 |
| inventory turnover | 1.15 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.12 |
| debt equity ratio | 0.16 |
| long term debt to capitalization | 0.03 |
| total debt to capitalization | 0.14 |
| interest coverage | -25.97 |
| cash flow to debt ratio | -3.35 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.51 |
| cash per share | 2.97 |
| operating cash flow per share | -1.37 |
| free cash flow operating cash flow ratio | 1.10 |
| cash flow coverage ratios | -3.35 |
| short term coverage ratios | -5.83 |
| capital expenditure coverage ratio | -10.35 |
Frequently Asked Questions
When was the last time Abeona Therapeutics Inc. (NASDAQ:ABEO) reported earnings?
Abeona Therapeutics Inc. (ABEO) published its most recent earnings results on 13-05-2026.
What is Abeona Therapeutics Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Abeona Therapeutics Inc. (NASDAQ:ABEO)'s trailing twelve months ROE is 41.4%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Abeona Therapeutics Inc. (ABEO) currently has a ROA of 33.32%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ABEO's net profit margin stand at?
ABEO reported a profit margin of 454.86% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ABEO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.89 in the most recent quarter. The quick ratio stood at 5.70, with a Debt/Eq ratio of 0.16.